Antex Biologics (ANTX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX)

ANTX 1.140

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Amigo Mike who wrote (1133)	1/28/1999 8:11:00 AM
From: John R Resseger	Read Replies (1) of 1476

Mike Do you know if the story made the Washington Post today? I find comfort in the following ... Antex had shown in preclinical models that the H. pylori vaccine was well- tolerated and generated both mucosal and systemic immune responses in vaccinated animals. The animal studies showed that the vaccine works both prophylactically and therapeutically; it prevented infection from H. pylori and cleared H. pylori in previously infected animals. Glaxo's $9 Billion Market Cap was based on Zantex which only treats the symtoms of what Antex Biologics' drug cures and prevents. How many Billions does Merck make peddeling Tagimet? ANTX's vaccine prevented and cured !! I'm going to revisit the Campylobactor animal tests.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next